Poll: Voters Prioritize Health Care Costs Ahead of 2026 Midterms
An Axios-Ipsos poll finds 61% of voters prioritize health care costs in 2026 elections.
Why it matters: Health care legal advisors should prepare for increased regulatory scrutiny and potential compliance challenges driven by voter demands for affordability and reform.
- 61% of voters say health care costs influence their 2026 midterm vote (Axios-Ipsos, June 2026).
- 45% favor candidates supporting renewal of Affordable Care Act subsidies.
- Over 60% back direct-to-consumer drug sales to lower medication costs.
- 26% may switch health plans due to rising premiums and copays, risking contract disputes.
A recent Axios-Ipsos American Health Index poll shows 61% of voters say health care costs will influence their vote in the 2026 midterms. This underscores affordability as a top issue amid rising premiums and out-of-pocket expenses driving consumer dissatisfaction.
Notably, 45% of respondents support candidates advocating renewal of the Affordable Care Act (ACA) subsidies, emphasizing ongoing reliance on these protections for coverage affordability. Additionally, over 60% back direct-to-consumer drug sales — a method where patients purchase medicines straight from manufacturers or pharmacies, bypassing traditional distribution channels, aimed at lowering prices.
Adults ages 30-49, parents, and lower-income households feel the cost pressures most: 26% are contemplating switching health plans due to premium and copay hikes. Such churn signals potential legal challenges concerning insurance contract compliance and state regulatory oversight.
This aligns with a United States of Care Action poll from April 2026, where 76% of voters said candidates’ health cost positions affect their votes, and 69% endorsed congressional action to ensure affordability. These poll findings indicate heightened legal and regulatory action is likely.
"Americans are deeply concerned about health care costs and look to officials for relief," Mallory Newall, Ipsos VP for U.S. Public Affairs, said in June 2026. "Broad support for cost-lowering solutions shows affordability shapes voter behavior." This political pressure increases risks of new laws targeting drug pricing, insurance practices, and innovative care delivery.
For legal professionals serving health care clients, these trends necessitate close monitoring of evolving legislation, regulatory enforcement, and contractual implications. The growth of direct-to-consumer drug sales particularly may spur legal innovations in compliance and transactional frameworks to address shifting market dynamics.
By the numbers:
- 61% — voters who say health care costs will influence their 2026 midterm vote.
- 45% — voters favoring ACA subsidy renewal to improve coverage affordability.
- 26% — voters considering switching health plans due to cost increases.
Yes, but: Strong voter interest does not guarantee immediate legislation; political uncertainty may delay regulatory changes, requiring legal teams to balance anticipation with caution.
What's next: Watch for mid-2026 legislative proposals targeting prescription drug pricing and insurance reforms following the midterm elections.